Postmodern medicine: An analysis of the pharmaceutical industry and its critics

Perspectives in Biology and Medicine

Volumn 56, Issue 2, 2013, Pages 223-235

  Nassir Ghaemi, S ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG INDUSTRY; POLICY; WRITING;

AUTHORSHIP; DRUG INDUSTRY; PUBLIC POLICY;

EID: 84883198064     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2013.0018     Document Type: Article

References (23)

1. Abramson, J. (2004). Overdosed America:The broken promise of American medicine. NewYork: HarperCollins.
2. Angell, M. (2004). The truth about the drug companies:How they deceive us and what to do about it. NewYork: Random House.
3. Ashley, D. (1997). History without a subject:The postmodern condition. Boulder:Westview Press.
4. Carlat, D. (2010). Unhinged:The trouble with psychiatry. NewYork: Free Press.
5. Ghaemi, S.N. (2007). Mood disorders:A practical guide. 2nd ed. Practical Guides in Psychiatry. Philadelphia: LippincottWillimans &Wilkins.
6. Ghaemi, S. N. (2008). Toward a Hippocratic psychopharmacology. Can J Psychiatry 53(3): 189-96.
7. Ghaemi, S. N. (2009). The rise and fall of the biopsychosocial model: Reconciling art and science in psychiatry. Baltimore: Johns Hopkins Univ. Press.
8. Ghaemi, S. N., et al. (2003). Antidepressants in bipolar disorder:The case for caution. Bipolar Disord 5(6):421-33.
9. Healy, D. (2001). The creation of psychopharmacology. Cambridge: Harvard Univ. Press.
10. Healy, D. (2012). Pharmageddon. Berkeley: Univ. of California Press.
11. Institute of Medicine (IOM). (1999). To err is human. Washington, DC: IOM.
12. James, W. (1897). Is life worth living. In The will to believe and other essays in popular philosophy. NewYork: Dover, 1956.
13. Johnston, S. C., S. L. Hauser, and S. Desmond-Hellmann. (2011). Enhancing ties between academia and industry to improve health. Nat Med 17:434-36.
14. Kaitin, K. I., N.R. Bryant, and L. Lasagna. (1993). The role of the research-based pharmaceutical industry in medical progress in the United States. J Clin Pharmacol 33:412-17.
15. Kaplan, E.A. (1993). Postmodernism and its discontents:Theories, practice. London:Verso.
16. Kassirer, J. E. (2005). On the take: How medicine's complicity with big business can endanger your health. NewYork: Oxford Univ. Press.
17. Kirsch, I. (2011). The emperor's new drugs. NewYork: Basic Books.
18. Moynihan, R., and A. Cassels. (2006). Selling sickness. NewYork: Nation Books.
19. Osler, W. (1932). Aequanimitas. 3rd ed. Philadelphia: Blakiston.
20. Torrey, E. F. (1997). Out of the shadows: Confronting America's mental illness crisis. NewYork: JohnWiley.
21. Vallance, P., P. Williams, and C. Dollery. (2010). The future is much closer: Collaboration between the pharmaceutical industry and academic medical centers. Clin Pharmacol Ther 87:525-27.
22. Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing rise of mental illness in America. NewYork: Crown.
23. Wootton, D. (2006). Bad medicine:Doctors doing harm since Hippocrates.Oxford:Oxford Univ. Press.